表紙:30ヶ国の体外診断(IVD)市場 - 2025年6月最新版
市場調査レポート
商品コード
1758238

30ヶ国の体外診断(IVD)市場 - 2025年6月最新版

30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 - June Update


出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.69円
30ヶ国の体外診断(IVD)市場 - 2025年6月最新版
出版日: 2025年06月27日
発行: Kalorama Information
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Kalorama Informationの30ヶ国の体外診断(IVD)市場 - 2025年6月最新版は、米国、中国、ドイツ、英国、サウジアラビア、インド、UAE、フランス、ベトナム、トルコなど主要30カ国の体外診断用医薬品(IVD)市場を包括的に分析しています。この詳細なレポートでは、詳細な市場規模、2029年および2030年の予測、2025年までの四半期ごとの更新をお届けし、進化する世界の体外診断用医薬品市場をタイムリーに洞察します。

20年以上にわたる市場調査の専門知識を活用し、Kalorama Informationは国レベルのアプローチを提示し、以下を含む重要なIVD分野の詳細な予測を提供します:

  • 血液バンクスクリーニング- 免疫
  • 凝固PT/ルーチン
  • クリティカルケア(コアラボ)
  • 一般化学検査
  • 血液学
  • 組織学
  • 免疫測定-マイクロ
  • 免疫測定-非ミクロ
  • 微生物学-ID/AST
  • 分子検査- その他
  • 分子血流/HAI
  • 分子HIV/肝炎
  • 分子呼吸器
  • POC救急救命
  • POC便潜血
  • POC血糖値(すべて)
  • POC感染症(すべて)
  • POC妊娠と不妊
  • その他の体外診断用医薬品
  • その他のPOC

当レポートは、国際的な市場開拓、規制の変更、M&A、新製品の発売など、主な市場促進要因を捉え、業界利害関係者に不可欠な情報を提供します。Kaloramaの30ヶ国の体外診断(IVD)市場 - 2025年6月最新版は、断片的な国別レポートとは異なり、包括的で実用的な市場情報を提供するという使命に沿い、これらの洞察を1つの権威あるリソースに集約しています。

目次

調査会社について

第1章 世界のIVD市場

第2章 米国のIVD市場

  • 米国のIVD市場概要
  • ニュース

第3章 ドイツのIVD市場

  • ドイツのIVD市場概要

第4章 中国

  • 中国のIVD市場概要

第5章 日本のIVD市場

  • 日本のIVD市場概要
  • ニュース

第6章:フランス

  • フランスのIVD市場概要

第7章 英国

  • 英国のIVD市場概要
  • ニュース

第8章 イタリア

  • イタリアのIVD市場概要

第9章 カナダ

  • カナダのIVD市場概要
  • ニュース

第10章 スペイン

  • スペインのIVD市場概要
  • ニュース

第11章 オーストラリア

  • オーストラリアのIVD市場概要

第12章 ブラジル

  • ブラジルのIVD市場概要

第13章 インド

  • インドのIVD市場概要

第14章 ロシア

  • ロシアのIVD市場概要

第15章 オランダ

  • オランダのIVD市場概要
  • ニュース

第16章 スイス

  • スイスのIVD市場概要
  • ニュース

第17章 ポーランド

  • ポーランドのIVD市場概要

第18章 トルコ

  • トルコのIVD市場概要

第19章 メキシコ

  • メキシコのIVD市場概要

第20章 スウェーデン

  • スウェーデンのIVD市場概要

第21章 ベルギー

  • ベルギーのIVD市場概要

第22章 オーストリア

  • オーストリアのIVD市場概要

第23章 サウジアラビア

  • サウジアラビアのIVD市場概要

第24章 韓国

  • 韓国のIVD市場概要
  • ニュース

第25章 エジプト

  • エジプトのIVD市場概要

第26章 ルーマニア

  • ルーマニアのIVD市場概要

第27章南 アフリカ

  • 南アフリカのIVD市場概要

第28章 インドネシア

  • インドネシアのIVD市場概要

第29章 チリ

  • チリのIVD市場概要

第30章 アラブ首長国連邦

  • アラブ首長国連邦のIVD概要

第31章 ベトナム

  • ベトナムのIVD市場概要
目次
Product Code: 25-020KA

Updated quarterly (four times a year) to reflect market changes

Kalorama Information's "30-Country IVD Market Atlas, 2025" provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape.

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

  • Blood Bank Screening - Immunos
  • Coagulation PT/Routine
  • Critical Care (core lab)
  • General Chemistries
  • Hematology
  • Histology
  • Immunoassays - Micro
  • Immunoassays - Non-Micro
  • Microbiology - ID/AST
  • Molecular - Other
  • Molecular Bloodstream/HAI
  • Molecular HIV & Hepatitis
  • Molecular Respiratory
  • POC Critical Care
  • POC Fecal Occult
  • POC Glucose (all)
  • POC Infectious Disease (all)
  • POC Pregnancy & Fertility
  • Other IVD
  • Other POC

The report captures key market drivers, including international developments, regulatory changes, mergers and acquisitions, and new product launches, providing essential intelligence for industry stakeholders. Unlike fragmented country-specific reports, Kalorama's "30-Country IVD Market Atlas, 2025" consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence.

Subscribers gain access to the report's quarterly updates via Kalorama's Knowledge Center, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.

TABLE OF CONTENTS

ABOUT KALORAMA INFORMATION

CHAPTER ONE: WORLDWIDE IVD MARKET

  • IVD MARKET DEMAND AND GROWTH
  • SCOPE AND METHODOLOGY
  • MARKET SEGMENTATION
  • COUNTRY ATLAS SCOPE
    • Table 1-1 - Key Interest Countries (30-Country Atlas) for IVD Markets, 2024 [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • LEADING COUNTRY REVENUES
    • Table 1-2: Global IVD Market by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
    • Figure 1-1: Global IVD Market by Leading Countries, Estimated 2024 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
    • Figure 1-2: Global IVD Market by Leading Countries, Forecasted 2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
    • Figure 1-3: Global IVD Market CAGR for Leading Countries, 2024-2029 (%) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

CHAPTER TWO: U.S. IVD MARKET

  • UNITED STATES IVD MARKET OVERVIEW
    • Table 2-1: U.S. IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other1, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 2-1: U.S. IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other1, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER THREE: GERMANY IVD MARKET

  • GERMANY IVD MARKET OVERVIEW
    • Table 3-1: Germany IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 3-1: Germany IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FOUR: CHINA

  • CHINA IVD MARKET OVERVIEW
    • Table 4-1: China IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 4-1: China IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FIVE: JAPAN IVD MARKET

  • JAPAN IVD MARKET OVERVIEW
    • Table 5-1: Japan IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 5-1: Japan IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER SIX: FRANCE

  • FRANCE IVD MARKET OVERVIEW
    • Table 6-1: France IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Figure 6-1: France IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER SEVEN: UNITED KINGDOM

  • UNITED KINGDOM IVD MARKET OVERVIEW
    • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER EIGHT: ITALY

  • ITALY IVD MARKET OVERVIEW
    • Table 8-1: Italy IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 8-1: Italy IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER NINE: CANADA

  • CANADA IVD MARKET OVERVIEW
    • Table 9-1: Canada IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 9-1: Canada IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER TEN: SPAIN

  • SPAIN IVD MARKET OVERVIEW
    • Table 10-1: Spain IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 10-1: Spain IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER ELEVEN: AUSTRALIA

  • AUSTRALIA IVD MARKET OVERVIEW
    • Table 11-1: Australia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 11-1: Australia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWELVE: BRAZIL

  • BRAZIL IVD MARKET OVERVIEW
    • Table 12-1: Brazil IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 12-1: Brazil IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER THIRTEEN: INDIA

  • INDIA IVD MARKET OVERVIEW
    • Table 13-1: India IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 13-1: India IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FOURTEEN: RUSSIA

  • RUSSIA IVD MARKET OVERVIEW
    • Table 14-1: Russia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 14-1: Russia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FIFTEEN: THE NETHERLANDS

  • THE NETHERLANDS IVD MARKET OVERVIEW
    • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER SIXTEEN: SWITZERLAND

  • SWITZERLAND IVD MARKET OVERVIEW
    • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER SEVENTEEN: POLAND

  • POLAND IVD MARKET OVERVIEW
    • Table 17-1: Poland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 17-1: Poland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER EIGHTEEN: TURKEY

  • TURKEY IVD MARKET OVERVIEW
    • Table 18-1: Turkey IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 18-1: Turkey IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER NINETEEN: MEXICO

  • MEXICO IVD MARKET OVERVIEW
    • Table 19-1: Mexico IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 19-1: Mexico IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY: SWEDEN

  • SWEDEN IVD MARKET OVERVIEW
    • Table 20-1: Sweden IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 20-1: Sweden IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-ONE: BELGIUM

  • BELGIUM IVD MARKET OVERVIEW
    • Table 21-1: Belgium IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 21-1: Belgium IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-TWO: AUSTRIA

  • AUSTRIA IVD MARKET OVERVIEW
    • Table 22-1: Austria IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 22-1: Austria IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-THREE: SAUDI ARABIA

  • SAUDI ARABIA IVD MARKET OVERVIEW
    • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-FOUR: SOUTH KOREA

  • SOUTH KOREA IVD MARKET OVERVIEW
    • Table 24-1: South Korea IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 24-1: South Korea IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • NEWS

CHAPTER TWENTY-FIVE: EGYPT

  • EGYPT IVD MARKET OVERVIEW
    • Table 25-1: Egypt IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 25-1: Egypt IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-SIX: ROMANIA

  • ROMANIA IVD MARKET OVERVIEW
    • Table 26-1: Romania IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 26-1: Romania IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-SEVEN: SOUTH AFRICA

  • SOUTH AFRICA IVD MARKET OVERVIEW
    • Table 27-1: South Africa IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 27-1: South Africa IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-EIGHT: INDONESIA

  • INDONESIA IVD MARKET OVERVIEW
    • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-NINE: CHILE

  • CHILE IVD MARKET OVERVIEW
    • Table 29-1: Chile IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 29-1: Chile IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER THIRTY: UNITED ARAB EMIRATES

  • UNITED ARAB EMIRATES IVD OVERVIEW
    • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER THIRTY-ONE: VIETNAM

  • VIETNAM IVD MARKET OVERVIEW
    • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
    • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]